Skip to content
healthcare.dev

ASPIRIN

NDC 50332-0139, ASPIRIN, tablet, from HART Health.

Product NDC
50332-0139
Status
Listed
Labeler
HART Health
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50332-0139 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPIRIN325 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]

Package NDCNDC-11Package
50332-0139-35033201390325 PACKET in 1 BOX, UNIT-DOSE (50332-0139-3) / 2 TABLET in 1 PACKET
50332-0139-45033201390450 PACKET in 1 BOX, UNIT-DOSE (50332-0139-4) / 2 TABLET in 1 PACKET
50332-0139-750332013907125 PACKET in 1 BOX, UNIT-DOSE (50332-0139-7) / 2 TABLET in 1 PACKET
50332-0139-850332013908250 PACKET in 1 BOX, UNIT-DOSE (50332-0139-8) / 2 TABLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50332-0139 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50332-0139 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50332-0139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.